We found that the NOD-like receptor signaling pathway was enriched in C1orf106 low expression, but the result seems different from that of the previous study (33), which may be one of the reasons why C1orf106 low expression promotes the infiltration of CD4+ T cells in DM patients. Here, CD4 is linked to dermatomyositis.